Quercetin In The Treatment Of SARS-COV 2

NCT04853199 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

SARS (Severe Acute Respiratory Syndrome)

Interventions

DRUG: Quercetin
DRUG: Placebo

Sponsor

Hôpital Universitaire Sahloul